U.S. STEM CELL, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 7 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-09-19: Reporting owner TOMAS MIKE; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-09-19: Reporting owner TOMAS MIKE; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-09-19: Reporting owner MURPHY WILLIAM P JR; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-09-19: Reporting owner Comella Kristin C; Form 4; Security Stock Options (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-09-19 | TOMAS MIKE Director, Officer (CEO & President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000,000 10,341,284 owned after | $0.02 exercise price | 2016-09-23 | |
| 2016-09-19 | TOMAS MIKE Director, Officer (CEO & President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 11,841,284 owned after | $0.02 exercise price | 2016-09-23 | |
| 2016-09-19 | MURPHY WILLIAM P JR Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 1,503,087 owned after | $0.02 exercise price | 2016-09-23 | |
| 2016-09-19 | Comella Kristin C Director, Officer (Chief Scientific Officer) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000,000 5,197,748 owned after | $0.02 exercise price | 2016-09-23 | |
| 2016-09-19 | Comella Kristin C Director, Officer (Chief Scientific Officer) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 6,697,748 owned after | $0.02 exercise price | 2016-09-23 | |
| 2016-09-19 | Borman Mark P Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 1,502,810 owned after | $0.02 exercise price | 2016-09-23 | |
| 2016-09-19 | Anderson Sheldon T. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 1,501,400 owned after | $0.02 exercise price | 2016-09-23 |